• About Us
    • About MS Australia
    • Our People
    • Partnerships
    • Reports and Financials
  • For People with MS
    • What is MS?
      • MS Symptoms
      • How is MS diagnosed?
      • Types of MS
      • MS Treatments
    • NMOSD and MOGAD
    • Health and Wellbeing
    • MS Nurses
    • MS Clinics
    • Employment
    • Participate in MS Research
    • Popular topics
    • For family, friends and other carers
    • Support and Services
    • Crisis Toolkit
    • COVID-19 and MS
  • FOR RESEARCHERS
    • Funding Opportunities
    • Online Grant Portal
    • MS Research Resource Portal
    • Grant Documents and Templates
    • Research We Fund
  • Research
    • Research We Fund
    • Research Strategy and Governance
    • National Collaborations
      • AHSCT
      • ANZgene
      • Ausimmune Study
      • Australian MS Longitudinal Study
      • EBV in MS
      • InforMS
      • MS Brain Bank
      • MS Clinical Trials
      • Proteomics of MS
      • PLATYPUS
      • Vitamin D MS Prevention Trial – PrevANZ
    • Global Collaborations
      • International Progressive MS Alliance
      • MS International Federation (MSIF)
      • The International MS Genetics Consortium
      • MS Brain Health
      • Kiss Goodbye to MS
    • Participate in MS Research
    • MS Glossary
  • Advocacy
    • Federal Election 2025
    • Alliances
    • Carer Strategy
    • Consumer Engagement Roadmap
    • Lived Experience Expert Panel
    • MS Nurses
    • NDIS
    • Parliamentary Friends of MS
    • Submissions
  • Get Involved
    • MS Australia Awards
    • World MS Day 2024
    • Ways to Donate
      • Donate
      • Leave a Gift in your Will
      • Workplace Giving
      • Give in Memory
      • Celebration donation
      • Your Contribution
      • Fundraise with The May 50K
      • Fundraise with Kiss Goodbye to MS
    • Participate in MS research
    • Events
    • Lived Experience Expert Panel
    • Corporate involvement
    • Volunteers
Menu
  • About Us
    • About MS Australia
    • Our People
    • Partnerships
    • Reports and Financials
  • For People with MS
    • What is MS?
      • MS Symptoms
      • How is MS diagnosed?
      • Types of MS
      • MS Treatments
    • NMOSD and MOGAD
    • Health and Wellbeing
    • MS Nurses
    • MS Clinics
    • Employment
    • Participate in MS Research
    • Popular topics
    • For family, friends and other carers
    • Support and Services
    • Crisis Toolkit
    • COVID-19 and MS
  • FOR RESEARCHERS
    • Funding Opportunities
    • Online Grant Portal
    • MS Research Resource Portal
    • Grant Documents and Templates
    • Research We Fund
  • Research
    • Research We Fund
    • Research Strategy and Governance
    • National Collaborations
      • AHSCT
      • ANZgene
      • Ausimmune Study
      • Australian MS Longitudinal Study
      • EBV in MS
      • InforMS
      • MS Brain Bank
      • MS Clinical Trials
      • Proteomics of MS
      • PLATYPUS
      • Vitamin D MS Prevention Trial – PrevANZ
    • Global Collaborations
      • International Progressive MS Alliance
      • MS International Federation (MSIF)
      • The International MS Genetics Consortium
      • MS Brain Health
      • Kiss Goodbye to MS
    • Participate in MS Research
    • MS Glossary
  • Advocacy
    • Federal Election 2025
    • Alliances
    • Carer Strategy
    • Consumer Engagement Roadmap
    • Lived Experience Expert Panel
    • MS Nurses
    • NDIS
    • Parliamentary Friends of MS
    • Submissions
  • Get Involved
    • MS Australia Awards
    • World MS Day 2024
    • Ways to Donate
      • Donate
      • Leave a Gift in your Will
      • Workplace Giving
      • Give in Memory
      • Celebration donation
      • Your Contribution
      • Fundraise with The May 50K
      • Fundraise with Kiss Goodbye to MS
    • Participate in MS research
    • Events
    • Lived Experience Expert Panel
    • Corporate involvement
    • Volunteers
NEWS
RESOURCES
PODCAST
  • NEWS
  • RESOURCES
  • PODCAST
  • VIDEOS
  • CONTACT
Donate
Subscribe
Search
  • About Us
    • About MS Australia
    • Our People
    • Partnerships
    • Reports and Financials
  • For People with MS
    • What is MS?
      • MS Symptoms
      • How is MS diagnosed?
      • Types of MS
      • MS Treatments
    • NMOSD and MOGAD
    • Health and Wellbeing
    • MS Nurses
    • MS Clinics
    • Employment
    • Participate in MS Research
    • Popular topics
    • For family, friends and other carers
    • Support and Services
    • Crisis Toolkit
    • COVID-19 and MS
  • FOR RESEARCHERS
    • Funding Opportunities
    • Online Grant Portal
    • MS Research Resource Portal
    • Grant Documents and Templates
    • Research We Fund
  • Research
    • Research We Fund
    • Research Strategy and Governance
    • National Collaborations
      • AHSCT
      • ANZgene
      • Ausimmune Study
      • Australian MS Longitudinal Study
      • EBV in MS
      • InforMS
      • MS Brain Bank
      • MS Clinical Trials
      • Proteomics of MS
      • PLATYPUS
      • Vitamin D MS Prevention Trial – PrevANZ
    • Global Collaborations
      • International Progressive MS Alliance
      • MS International Federation (MSIF)
      • The International MS Genetics Consortium
      • MS Brain Health
      • Kiss Goodbye to MS
    • Participate in MS Research
    • MS Glossary
  • Advocacy
    • Federal Election 2025
    • Alliances
    • Carer Strategy
    • Consumer Engagement Roadmap
    • Lived Experience Expert Panel
    • MS Nurses
    • NDIS
    • Parliamentary Friends of MS
    • Submissions
  • Get Involved
    • MS Australia Awards
    • World MS Day 2024
    • Ways to Donate
      • Donate
      • Leave a Gift in your Will
      • Workplace Giving
      • Give in Memory
      • Celebration donation
      • Your Contribution
      • Fundraise with The May 50K
      • Fundraise with Kiss Goodbye to MS
    • Participate in MS research
    • Events
    • Lived Experience Expert Panel
    • Corporate involvement
    • Volunteers
Menu
  • About Us
    • About MS Australia
    • Our People
    • Partnerships
    • Reports and Financials
  • For People with MS
    • What is MS?
      • MS Symptoms
      • How is MS diagnosed?
      • Types of MS
      • MS Treatments
    • NMOSD and MOGAD
    • Health and Wellbeing
    • MS Nurses
    • MS Clinics
    • Employment
    • Participate in MS Research
    • Popular topics
    • For family, friends and other carers
    • Support and Services
    • Crisis Toolkit
    • COVID-19 and MS
  • FOR RESEARCHERS
    • Funding Opportunities
    • Online Grant Portal
    • MS Research Resource Portal
    • Grant Documents and Templates
    • Research We Fund
  • Research
    • Research We Fund
    • Research Strategy and Governance
    • National Collaborations
      • AHSCT
      • ANZgene
      • Ausimmune Study
      • Australian MS Longitudinal Study
      • EBV in MS
      • InforMS
      • MS Brain Bank
      • MS Clinical Trials
      • Proteomics of MS
      • PLATYPUS
      • Vitamin D MS Prevention Trial – PrevANZ
    • Global Collaborations
      • International Progressive MS Alliance
      • MS International Federation (MSIF)
      • The International MS Genetics Consortium
      • MS Brain Health
      • Kiss Goodbye to MS
    • Participate in MS Research
    • MS Glossary
  • Advocacy
    • Federal Election 2025
    • Alliances
    • Carer Strategy
    • Consumer Engagement Roadmap
    • Lived Experience Expert Panel
    • MS Nurses
    • NDIS
    • Parliamentary Friends of MS
    • Submissions
  • Get Involved
    • MS Australia Awards
    • World MS Day 2024
    • Ways to Donate
      • Donate
      • Leave a Gift in your Will
      • Workplace Giving
      • Give in Memory
      • Celebration donation
      • Your Contribution
      • Fundraise with The May 50K
      • Fundraise with Kiss Goodbye to MS
    • Participate in MS research
    • Events
    • Lived Experience Expert Panel
    • Corporate involvement
    • Volunteers
DMTs: Impact of access on quality of life 18 October 2021
MS Brainbank MS News MS Trials
DMTs: Impact of access on quality of life
NHMRC commits over $6.7 million to medical research into MS 6 October 2021
MS Brainbank MS News MS Trials
NHMRC commits over $6.7 million to medical research into MS
MS healthcare during the COVID-19 pandemic: the value of telehealth 13 September 2021
MS Brainbank MS News MS Trials
MS healthcare during the COVID-19 pandemic: the value of telehealth
Measuring immune effects of vitamin D in MS 13 September 2021
MS Brainbank MS News MS Trials
Measuring immune effects of vitamin D in MS
Tracking work productivity of Australians living with MS 13 September 2021
MS Brainbank MS News MS Trials
Tracking work productivity of Australians living with MS
Is there enough support for people with MS to stop smoking? 17 August 2021
MS Brainbank MS News MS Trials
Is there enough support for people with MS to stop smoking?
Repurposing old drugs: the hunt for progressive MS treatments targeting remyelination 16 August 2021
MS Brainbank MS News MS Trials
Repurposing old drugs: the hunt for progressive MS treatments targeting remyelination
MS disease modifying therapy, Aubagio® (​teriflunomide), to be delisted 22 July 2021
MS Brainbank MS News MS Trials
MS disease modifying therapy, Aubagio® (​teriflunomide), to be delisted
Partnership grant to improve decisions about accessing stem cell-based therapies 19 July 2021
MS Brainbank MS News MS Trials
Partnership grant to improve decisions about accessing stem cell-based therapies
MS risk and relapses: unlocking new clues from our genes 14 July 2021
MS Brainbank MS News
MS risk and relapses: unlocking new clues from our genes
Load More
MS Australia
registered charity

1300 010 158

info@msaustralia.org.au

Head Office

Suite 3.01, 18 Flour Mill Way
Summer Hill NSW 2130

Participate in MS Research

  • MS Clinical Trials
  • MS Australia Brain Bank
  • Australian MS Longitudinal Study
Facebook-f X-twitter Linkedin-in Youtube Spotify Paper-plane

Quick links

  • What is MS?
  • How is MS diagnosed?
  • COVID-19 and MS
  • Research funding opportunities
  • Research we fund
  • Media enquiries
  • Contact us
© 2025 Multiple Sclerosis Australia | ABN: 51 008 515 508 │Privacy Policy | Whistleblower Policy | Complaints Policy | Terms and Conditions
© 2024 Multiple Sclerosis Australia
ABN: 51 008 515 508
Privacy Policy | Whistleblower Policy
Complaints Policy | Terms and Conditions
SUBSCRIBE
DONATE
CONTACT

Newsletter subscription

  • Enter your details

DMTs: Impact of access on quality of life